This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kumar, V. Articles by Jablonska, S. Search for Related Content PubMed PubMed Citation Articles by Kumar, V. Articles by Jablonska, S.

Celiac Disease and Immunoglobulin A Deficiency: How Effective Are the Serological Methods of Diagnosis?

IMMCO Diagnostics, Inc., Buffalo, New York 14228,¹ Departments of Microbiology and Dermatology, State University of New York at Buffalo, Buffalo, New York 14214,² Department of Dermatology, Warsaw School of Medicine,³ Department of Gastroenterology and Pediatrics, Silesian School of Medicine, Warsaw, Poland⁴

Received 29 April 2002/ Returned for modification 1 July 2002/ Accepted 23 July 2002

Immunoglobulin A (IgA) deficiency is 10 to 15 times more common in patients with celiac disease (CD) than in healthy subjects. Serological tests have become the preferred methods of diagnosing CD in both symptomatic and asymptomatic patients. However, commercially available serological methods are limited in that they detect only the IgA isotype of antibodies (with the exception of IgG gliadin assays); hence, IgA-deficient patients with CD may yield false-negative serology. Fifteen pediatric patients with CD and 10 IgA-deficient pediatric patients without CD were examined for IgA and IgG antibodies to endomysium, gliadin, and tissue transglutaminase. Twenty-five specimens from patients with IgA deficiency were examined. Fifteen were from patients with CD, and 10 were patients without CD. All 15 IgA-deficient patients with CD were positive for endomysium antibodies of the IgG isotype and for IgG gliadin antibodies. All but one of the IgA-deficient patients with CD were also positive for IgG tissue transglutaminase antibodies. None of the IgA-deficient patients without CD were positive for any of the antibody markers. All the specimens examined were also negative for IgA-specific antibodies to endomysium, gliadin, and tissue transglutaminase. IgG-specific antibody tests for endomysium, gliadin, and tissue transglutaminase are useful for the identification of IgA-deficient patients with CD. IgG antibody tests along with tests routinely being used in clinical laboratories can reliably detect all active patients with CD. In addition, the levels of these CD-specific IgG antibodies could be used to monitor patient dietary compliance.

This article has been cited by other articles:

• Dahlbom, I., Olsson, M., Forooz, N. K., Sjoholm, A. G., Truedsson, L., Hansson, T. (2005). Immunoglobulin G (IgG) Anti-Tissue Transglutaminase Antibodies Used as Markers for IgA-Deficient Celiac Disease Patients. CVI 12: 254-258 [Abstract] [Full Text]  
• Korponay-Szabo, I R, Dahlbom, I, Laurila, K, Koskinen, S, Woolley, N, Partanen, J, Kovacs, J B, Maki, M, Hansson, T (2003). Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency. Gut 52: 1567-1571 [Abstract] [Full Text]